NEWS
You can follow the latest news of MicroViable in this section
Microviable will be attending HLTH 2023. Las Vegas, October 8-11
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and our CBO, Rafael M. Permuy, MBA, will be attending HLTH 2023 event in Las Vegas (USA) from October 8th to 11th. HLTH 2023 is the preeminent event [...]
Microbiota and Infectious Disease Treatments: A Solution to Antibiotic Resistance
In today's world, antibiotic resistance and multi-resistant bacteria pose a challenge to modern medicine. Innovative therapies involving microbiota and treatments for infectious diseases offer a promising solution to address this issue. The diverse community of [...]
Microviable Therapeutics will be attending BioSpain 2023
Claudio Hidalgo, CEO at Microviable, will be attending BioSpain 2023, one of the largest international biotechnology events in southern Europe, will take place from 26-28 September 2023 in Barcelona thanks to a coordinated collaboration of [...]
Microviable will be presenting at Farmaforum 2023
Microviable Therapeutics will be presenting at Farmaforum 2023 taking place on September 20th-21th at Madrid. The Microviable team will consist of Claudio Hidalgo, CEO of the company, and Noelia Martínez, R&D Director. Noelia Martínez will [...]
Pilar Manrique, Research Scientist at Microviable Therapeuthics, talks about the donor-based microbiome therapeutic products research and development.
During the Microbiome Connect Europe conference, held early in July in Amsterdam, Microbiome Post sat down with Pilar Manrique Ronquillo, Research Scientist at Microviable Therapeuthics, to learn more about the donor-based microbiome therapeutic products research and [...]
Microviable Therapeutics seeks more than five million to secure a clinical trial
Microviable Therapeutics, which develops oral drugs based on microbiota-derived products, hopes to soon open a financing round of more than five million euros to advance its research toward the clinical phase, according to Claudio Hidalgo, [...]